Co-Chief Executive Officer & Chief Financial Officer
Pay Cher Wee serves as the Co-Chief Executive Officer & Chief Financial Officer (CFO) of Juniper Biologics, overseeing the global businesses, operations and financials of the organization.
Cher Wee is an accomplished strategy and finance executive with extensive leadership experience across various industries. He brings a wealth of expertise, accumulated over 30 years, in financial management, strategic planning, and operational excellence.
Cher Wee started his career as an auditor in Deloitte before embarking on his journey as a corporate executive in listed, privately held and government related organizations. Cher Wee served as the CFO at Venture Corporation Limited, Raffles Medical Group Ltd and Beyonics Pte Ltd. He also held leadership roles at Jurong Port Pte Ltd as its CFO and President of Business Units. He was the Chairman at Jurong Port Universal Terminal Pte Ltd, one of Asia Pacific’s largest independently operated tank terminals. He played key roles in growing the businesses, maintaining strong financial performances and pursuing operational excellence in these organizations.
An entrepreneur at heart, Cher Wee co-founded Accion Capital Management Pte Ltd, a Monetary Authority of Singapore registered fund management company. Prior to this, he served as Executive Vice President at GKG Investments Holdings, overseeing private and public investments in the Asia region.
Cher Wee graduated with a Bachelor in Accountancy degree from Nanyang Technological University. His commitment to giving back to the community is evident through his active involvement in local volunteer work, including serving on the Board of Directors for the Singapore Cancer Society from 2009 to 2015.
Co-CEO & Vice President and Regional General Manager of ANZ
Maulik Shroff serves as the Co-Chief Executive Officer and Vice President and General Manager for Juniper Biologics in Australia and New Zealand. With over 20 years of experience in the pharmaceutical industry, Maulik has worked across diverse geographies, including India, Australia, and the Asia Pacific region.
He began his pharmaceutical career in India with Emcure, where he held various sales and sales management roles. Maulik then transitioned to the Australian market, working with prominent companies such as Eli Lilly, Novartis, and Mundipharma before joining Juniper Biologics. Throughout his career, he has excelled in numerous commercial and leadership positions.
Maulik is passionate about building high-performing teams to drive commercial innovation and improve patient outcomes.
Maulik holds a Bachelor's degree in Biochemistry from India and a Master's degree in Engineering with a focus on Information Technology from RMIT University in Melbourne, Australia.
Chief Commercial Officer & Vice President and Regional General Manager of North Asia
Benedict Ong serves as the Chief Commercial Officer of Juniper Biologics, overseeing the commercial strategies of the company for both existing portfolio and new products planning. Also as the Vice President & Regional General Manager for the North Asia cluster including China, Japan, Korea and Taiwan, he is managing the business and operation to drive growth and opportunities.
Benedict has more than 25 years’ of commercial experiences in the healthcare sector, pharmaceutical and medical device industries. He brings wealth of knowledge and experience across various therapeutic areas including oncology, haematology, anti-infectives, primary care and neuroscience.
He started his career as a junior product specialist before embarking on a journey of various commercial roles with increasing responsibilities with pharmaceutical MNCs including Bayer, Janssen (a Johnson & Johnson company) and Roche. Benedict held senior Oncology Marketing Leadership roles in Southeast Asia in Janssen and later served as Commercial Director for Foundation Medicine in Asia Pacific, Roche. He played key roles in driving commercial excellence and growing the business in territories assigned under his care.
Benedict attained a Master of Business Administration from the University of Birmingham and a Bachelor of Science in Pharmacy from National University of Singapore. He is also a registered pharmacist with the Singapore Pharmaceutical Council.
Vice President and Regional General Manager of SEA
Suresh Pragasam serves as Vice President and Regional General Manager of Juniper Biologics for its Southeast Asia pharmaceutical operations.
Prior to Juniper, Suresh has 30 years of pharmaceutical experiences across multiple functions, such as sales, marketing, commercial excellence, strategic and business development, and general management with multinational pharmaceutical companies such as GlaxosmithKline, UCB Pharmaceuticals, Sanofi and Mundipharma.
His last position before joining Juniper was as Regional General Manager for Mundipharma for Southeast Asia, Korea, Taiwan, and Hong Kong.
Suresh’s notable successes across Southeast Asia amongst others were maximising post-patent portfolios, new products introduction and launches into new and existing countries, development of Patient Access Programs, integration of newly acquired products, restructuring and turning around of non-profitable companies, Bbuilding and developing people and teams. Suresh was seconded to Brazil and Mexico during his tenure with Sanofi.
Suresh graduated with a Masters in Business Administration from Edith Cowan University, Australia. In addition, Suresh also completed General Management Programs in INSEAD Paris and INSEAD Singapore.
Vice President and Regional General Manager of MEA
Haytham Ramzy serves as Vice President & General Manager, Middle-East & Africa for Juniper Biologics.
Haytham has over 16 years of pharmaceutical experience where he is most recently the Cluster Head in Egypt and Near East. Haytham is a strategic and results-oriented leader with a successful track record in the pharmaceutical industry, partnering CEOs and Boards, leading stakeholder and employee engagement.
As Vice President & General Manager, MEA, Haytham will provide strategic direction to the region’s operations including all sales, marketing, reporting and compliance plans. He will be responsible for establishing Juniper Biologics operations and building long-term partnerships with healthcare professionals, patient groups and government bodies.
He will be an important link between Juniper Biologics and channel partners in the MEA region, and will be accountable for all business development activities, with the aim of growing Juniper Biologics’ business portfolio.
Global Medical Director
Dr. Vimal Sathiaseelan serves as Global Medical Director for Juniper Biologics. He brings over 15 years of experience in healthcare, serving as a clinician and leadership Medical Affairs roles.
Prior to Juniper, Vimal has many years of experience with multinational pharmaceutical companies such as GSK and Astellas. He has deep expertise in various therapeutic areas including oncology, haematology, immunology, anti-infectives and specialty care.
Vimal brings with him proven track record in guiding medical affairs teams across various regions, spearheading successful product launches, strategic business acumen, fostering scientific engagements, establishing external partnerships and providing oversight on pharmacovigilance and quality assurance.
Vimal holds a medical degree from Crimea State Medical University, Ukraine and certifications in Health Economics from Monash, Data Analytics from London School of Economics and Medical Affairs from DUKE-NUS.
Chief Human Resource Officer
Joyce Ng is the Chief Human Resource Officer of Juniper Biologics overseeing the global People, Administration, and Internal Communication function of the organization.
Prior to joining Juniper, Joyce has spent over the last 13 years navigating the dynamic landscapes of human resources, honing her skills in the full spectrum of HR as a business partner. Her journey has taken her through diverse industries, such as oil/ gas trading, luxury retail, professional services consultancy, technology, and Fin-tech, and at various stages from early fundraising series in start-ups to post-acquisition harmonization into established listed corporations. She is particularly familiar with the APAC region; having experience in senior internal and external stakeholders management throughout Asia and Oceania countries.
Joyce graduated with a Bachelor in Business from University of London, the London School of Economics and Political Science, Post-graduate Diploma in HR and Talent Management from Singapore Human Resource Institute and a Global HR Leadership Professional Program with National University of Singapore.